|
Orthologous residues
|
|
KPNA2 (human): K22‑a, KPNA2 (mouse): K22‑a
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site
|
|
Disease tissue studied:
colorectal cancer, colorectal carcinoma
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial) [KPNA2 (human)], RKO (intestinal)
|
|
Cellular systems studied:
cell lines
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
ACETYLTRANSFERASE
|
p300 (human)
|
transfection of wild-type enzyme
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation, intracellular localization, molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
HuR (human)
|
|
Induces
|
intracellular localization
|
|
co-immunoprecipitation
|
|
|
Comments:
promotes the nuclear localization of HuR
|